Albert Bourla, Pfizer CEO (John Thys, Pool via AP Images)
How much? Pfizer expects to reap at least $26B from Covid vaccine in 2021
Pfizer’s Covid-19 vaccine is likely to bring in about $26 billion in 2021 revenues, which is more than $10 billion more than the biopharma behemoth …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
